What to expect at the
New Product Planning Summit

 

The New Product Planning Summit is the leading conference for defining how the new product planning role and related functions make informed, value-based, data-driven decisions about products in the pipeline.

Life science industry professionals gather here each year to consider how and when to utilize various resources and ask the right questions to ensure commercial success. Now in its fifth year, the New Product Planning Summit has the largest and most diverse speaking faculty yet, allowing us to cover in-depth topics benefiting drug, biotech, and device manufacturers of all different sizes. Our new virtual structure allows you to submit questions to speakers during live Q&A, network with colleagues in structured zoom breakout rooms, and view sessions on-demand up to 6 months after.

Join us in February 2021 to become a part of this growing community of eager professionals who are navigating the New Product Planning space during these uncertain times.

 

   Who Attends

This conference attracts SVPs, VPs, Directors, Heads and Managers from the pharmaceutical and biotechnology industries whose responsibilities include:

New Product Planning/Commercialization/Development

Commercial Assessment/Strategy

Competitive/Business Intelligence

Market Research

Business/Strategic Planning

Global/Strategic Marketing

Product Development

Portfolio/Product/Brand/Lifecycle Management

Publication Planning

Research and Development

Brand Commercialization

Health Economics and Outcomes Research

Market Access/Pricing

Reimbursement Strategy

Medical Strategy

Regulatory Affairs/Compliance

Medical Affairs

Intellectual Property/Legal

Scientific/Medical Communication

Publication Planning

Managed Markets/Care Strategy

Business Development

Licensing

 

 

  
   Past Participants of the New Product Planning Summit Include

Akebia Therapeutics

Alexion Pharmaceuticals

Alkermes

BeiGene

Boston Pharmaceuticals

Celgene

Daiichi Sankyo

Emergent BioSolutions

Genentech

Heron Therapeutics

Indegene

Kyowa Kirin Pharmaceutical Development

LEO Pharma

Lundbeck

Otsuka

Sanofi Genzyme

Theravance Biopharma

United Therapeutics